This was the dosage regime for pediatric P3 aGVHD trial
"Subjects will be treated with intravenous (IV) remestemcel-L at a dose of 2 x 10e6 MSC/kg (actual body weight at screening) twice per week for each of 4 consecutive weeks."
So you yes 8 versus 2 doses, not sure of number of cells/kg rate though. I haven't been able to find the CTSN/NIH trial yet, maybe I'm using wrong search terms?
VILI and MSCs, page-13
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.11 |
Change
0.000(0.00%) |
Mkt cap ! $1.270B | |||
| Open | High | Low | Value | Volume |
| $1.13 | $1.16 | $1.10 | $5.436M | 4.861M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 18 | 121539 | $1.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.11 | 70312 | 17 |
View Market Depth
| Last trade - 14.12pm 08/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |